Pulse Biosciences (PLSE) Cash from Financing Activities (2017 - 2025)

Pulse Biosciences' Cash from Financing Activities history runs 9 years deep, the most recent figure standing at $381000.0 for Q4 2025.

• In Q4 2025, Cash from Financing Activities fell 99.21% year-over-year to $381000.0; the TTM figure through Dec 2025 stood at $17.2 million (down 84.43% YoY), while the FY2025 annual figure was $17.2 million, down 84.43% from the prior year.
• Cash from Financing Activities was $381000.0 for Q4 2025 at Pulse Biosciences, down from $2.0 million in the prior quarter.
• In the past five years, Cash from Financing Activities ranged from a high of $65.1 million in Q3 2022 to a low of -$549000.0 in Q4 2021.
• Historically, Cash from Financing Activities has averaged $15.1 million across 5 years, with a median of $2.1 million in 2023.
• The sharpest annual moves came in 2021 and 2023: Cash from Financing Activities surged 19278.03% in 2021, then sank 564.62% in 2023.
• A 5-year view of Cash from Financing Activities shows it stood at -$549000.0 in 2021, then jumped by 96.9% to -$17000.0 in 2022, then surged by 4829.41% to $804000.0 in 2023, then soared by 5895.27% to $48.2 million in 2024, then slumped by 99.21% to $381000.0 in 2025.
• The last three Cash from Financing Activities figures came in at $381000.0 (Q4 2025), $2.0 million (Q3 2025), and $14.8 million (Q1 2025), per Business Quant data.